SQZ Biotechnologies

NYSE: SQZ · Real-Time Price · USD
0.43
0.16 (59.26%)
At close: Jul 03, 2023, 7:00 PM

SQZ Biotechnologies Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
63.71M 143.51M
Short-Term Investments
n/a n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
2.31M 2.63M
Receivables
384K 3.1M
Inventory
-384K -95K
Other Current Assets
4.5M 4.12M
Total Current Assets
68.2M 150.63M
Property-Plant & Equipment
29.39M 72.89M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
31.7M 75.52M
Total Assets
99.9M 226.15M
Account Payables
2.51M 3.97M
Deferred Revenue
715K 12.51M
Short-Term Debt
6.56M 9.94M
Other Current Liabilities
12.05M 6.81M
Total Current Liabilities
21.84M 33.22M
Long-Term Debt
20.91M 59.76M
Other Long-Term Liabilities
n/a n/a
Total Long-Term Liabilities
20.91M 68.95M
Total Liabilities
42.75M 102.18M
Total Debt
27.47M 69.69M
Common Stock
29K 28K
Retained Earnings
-274.97M -195.51M
Comprehensive Income
n/a n/a
Shareholders Equity
57.15M 123.98M
Total Investments
n/a n/a